Evidence map›Paper›PMID 26749495›Full record

ArticleCancer science2016

GANP protein encoded on human chromosome 21/mouse chromosome 10 is associated with resistance to mammary tumor development.

Kazuhiko Kuwahara, Mutsuko Yamamoto-Ibusuki, Zhenhuan Zhang, Suchada Phimsen, Naomi Gondo, Hiroko Yamashita, Toru Takeo, Naomi Nakagata, Daisuke Yamashita, Yoshimi Fukushima and 8 more

Open access · goldAbstract read
In one paragraph

Article in Cancer science, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Increased chemosensitivity via BRCA2-independent DNA damage in DSS1- and PCID2-depleted breast carcinomas.Laboratory investigation; a journal of technical methods and pathology · 2021
    Article
  8. Roles of Non-coding RNAs and Angiogenesis in Glioblastoma.Frontiers in cell and developmental biology · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 1 country.

Kazuhiko KuwaharaDepartment of Immunology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Mutsuko Yamamoto-IbusukiDepartment of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Zhenhuan ZhangDepartment of Immunology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Suchada PhimsenDepartment of Immunology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Naomi GondoDivision of Immunology, Aichi Cancer Center Research Institute, Nagoya, Japan.
Hiroko YamashitaDivision of Breast and Endocrine Surgery, Hokkaido University Hospital, Sapporo, Japan.
Toru TakeoDivision of Reproductive Engineering, Center for Animal Resources and Development, Kumamoto University, Kumamoto, Japan.
Naomi NakagataDivision of Reproductive Engineering, Center for Animal Resources and Development, Kumamoto University, Kumamoto, Japan.
Daisuke YamashitaDivision of Oncological Pathology, Aichi Cancer Center Research Institute, Nagoya, Japan.
Yoshimi FukushimaDepartment of Immunology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Yutaka YamamotoDivision of Immunology, Aichi Cancer Center Research Institute, Nagoya, Japan.
Hiroji IwataDepartment of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
Hideyuki SayaDivision of Gene Regulation, Institute for Advanced Medical Research, Graduate School of Medicine, Keio University, Tokyo, Japan.
Eisaku KondoDivision of Oncological Pathology, Aichi Cancer Center Research Institute, Nagoya, Japan.
Keitaro MatsuoDivision of Molecular Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan.
Motohiro TakeyaDepartment of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Hirotaka IwaseDepartment of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Nobuo SakaguchiDepartment of Immunology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Kumamoto University · JPAichi Cancer Center · JPHokkaido University Hospital · JPKeio University · JPNiigata University · JPOsaka University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human chromosome 21 is known to be associated with the high risk of hematological malignancy but with resistance to breast cancer in the study of Down syndrome. In human cancers, we previously observed the significant alterations of the protein expression encoded by the ganp/MCM3AP gene on human chromosome 21q22.3. Here, we investigated GANP protein alterations in human breast cancer samples (416 cases) at various stages by immunohistochemical analysis. This cohort study clearly showed that expression of GANP is significantly decreased in human breast cancer cases with poor prognosis as an independent risk factor (relapse-free survival, hazard ratio = 2.37, 95% confidence interval, 1.27-4.42, P = 0.007 [univariate analysis]; hazard ratio = 2.70, 95% confidence interval, 1.42-5.13, P = 0.002 [multivariate analysis]). To investigate whether the altered GANP expression is associated with mammary tumorigenesis, we created mutant mice that were conditionally deficient in the ganp/MCM3AP gene using wap-cre recombinase transgenic mice. Mammary gland tumors occurred at a very high incidence in female mammary gland-specific GANP-deficient mice after severe impairment of mammary gland development during pregnancy. Moreover, tumor development also occurred in female post parous GANP-heterodeficient mice. GANP has a significant role in the suppression of DNA damage caused by estrogen in human breast cancer cell lines. These results indicated that the GANP protein is associated with breast cancer resistance.

Indexed as

AcetyltransferasesAdultAgedAnimalsBreast NeoplasmsCarcinogenesisCell Line, TumorChromosomes, Human, Pair 10DNA DamageEstrogensFemaleGene Expression Regulation, NeoplasticHumansIntracellular Signaling Peptides and ProteinsMammary Neoplasms, AnimalMiceAcetyltransferasesEstrogensIntracellular Signaling Peptides and ProteinsMCM3AP protein, humanBreast cancer resistancechromosome 21DNA damagedown syndromeganp/MCM3APprognostic factor

Identifiers

PMID26749495
PMCPMC4832866
OpenAlexW2222379736

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.